EU tobacco tax plans are being scaled back

Europe is stepping back from a chance to prevent lung cancer.

Europe is stepping back from a chance to prevent disease before it starts.

A new draft proposal from EU Member States would weaken planned increases in tobacco taxation, slowing one of the most effective tools we have to reduce smoking and prevent lung cancer.

Tobacco tax can sound technical. But the consequences are very human.

We know from decades of evidence that higher tobacco taxes reduce smoking, particularly among young people and those on lower incomes. They help stop people starting, support those who want to quit, and reduce the long-term burden of disease on families and health systems.

Lung cancer remains the leading cause of cancer death in Europe. While we are finally seeing progress in treatment and survival, prevention is still where the biggest gains can be made. It is also where policy choices have the biggest impact on equity, because weak prevention always hits the same communities hardest.

In the draft now circulating in Council discussions, both the proposed tax levels and the pace of implementation are weaker than earlier plans. And those differences add up. Lower and slower increases blunt the impact on smoking rates and allow more people to become or remain dependent on tobacco.

It’s also important to acknowledge the concerns some Member States raise. Countries with lower incomes often worry that higher taxes will fuel illicit trade rather than reduce smoking. That is a real challenge, and it deserves serious attention. But it is a challenge best addressed through stronger cross-border cooperation, enforcement, and tracking, not by lowering public health ambition.

There are also ongoing debates about how newer nicotine products should be taxed. Some governments argue that taxing e-cigarettes and heated tobacco in the same way as cigarettes removes incentives for people to switch away from smoking. The evidence here is still evolving, and policies need to be designed carefully to avoid unintended consequences, particularly for young people and those who have never smoked.

But none of these complexities change the central point. Combustible tobacco remains the single biggest driver of lung cancer. Strong, evidence-based taxation is one of the most effective ways to reduce its use.

More than 120 health and civil society organisations, including Lung Cancer Europe, have already called for an ambitious update of Europe’s tobacco rules. That call was grounded in one simple idea: if we are serious about reducing lung cancer, prevention cannot be the first thing dropped when compromises are made.

In line with our Call to Action, United Against Lung Cancer, Lung Cancer Europe urges the European Commission and Member States to deliver on their commitments under the WHO Framework Convention on Tobacco Control, without further delay.

There is also a wider issue at play. Lung cancer remains heavily stigmatised, and that stigma shapes policy choices. When a disease is seen as self-inflicted, it becomes easier to accept weaker action, even when the evidence is clear. That has real consequences for people’s lives.

Strong tobacco taxation, alongside accessible and compassionate support for people who want to quit, saves lives. It reduces inequality, supports earlier diagnosis, and eases pressure on already stretched health systems.

This moment was an opportunity to show that lung cancer prevention is taken seriously in Europe. Instead, we are left with a plan that risks losing momentum at a time when stronger action is still needed.